Physician

Thomas J Wente, DO

According to 2025 Medicare claims, Thomas Wente, DO (NPI: 1538134002) practices family practice in the Sioux City, IA-NE-SD market, with the plurality of this provider's patient population coming from Woodbury, IA. This provider's primary affiliated billing organization is FAMILY HEALTH CARE OF SIOUXLAND PLC (NPI: 1437170685; TIN: 753057963) and primary practice location at 68776-3144. Wente is affiliated with the Stratum Med ACO (ACO ID: A4527) and Avera Prairie View ACO (ACO ID: A4692), participating under the MSSP model.

Wente's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 367 traditional Medicare patients, billed 18,873 HCPCS/CPT codes, and received $210,058 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 15,840 prescription claims across 655 beneficiaries totaling $1,422,828 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 567 claims. Open Payments data shows 74 records totaling $1,320. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $705,337 to $1,422,828. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $41,362 and ending at $26,824.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	436	8,021	$179,811
2016	481	8,403	$173,579
2017	506	9,118	$186,895
2018	523	8,691	$215,625
2019	526	11,193	$253,005
2020	466	10,817	$230,079
2021	411	15,304	$282,373
2022	400	12,868	$172,679
2023	367	12,730	$177,021
2024	367	18,873	$210,058

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	568	13,316	$705,337
2016	634	13,578	$639,322
2017	681	14,010	$632,399
2018	747	14,555	$757,747
2019	695	15,984	$894,741
2020	667	15,345	$979,672
2021	623	14,398	$1,059,077
2022	627	14,215	$1,194,574
2023	625	15,101	$1,419,107
2024	655	15,840	$1,422,828

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	140	707	$38,681
2016	158	722	$26,857
2017	200	628	$16,662
2018	215	693	$16,681
2019	228	766	$23,713
2020	289	857	$32,094
2021	263	846	$34,078
2022	201	709	$33,291
2023	197	673	$28,806
2024	192	567	$21,459

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	343	857	$41
80053	Blood test, comprehensive group of blood chemicals	293	462	$10
36415	Insertion of needle into vein for collection of blood sample	337	722	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	325	572	$8
81001	Manual urinalysis test with examination using microscope, automated	284	483	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	275	11,501	$210,971
Eliquis	Apixaban	257	10,887	$203,180
Ozempic	Semaglutide	144	4,788	$155,349
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	141	4,860	$103,241
Trulicity	Dulaglutide	71	1,988	$69,853

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7032	Cushion for use on nasal mask interface, replacement only, each	N	24	49	$5,255
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	47	$3,261
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	30	68	$3,176
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	45	$1,620
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	N/R	18	$1,244

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	74	$1,320	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas J. Wente, DO?

Tedicare shows public-source Medicare data for Thomas J. Wente, DO (NPI 1538134002), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas J. Wente, DO have ACO affiliation data?

Thomas J. Wente, DO is shown with ACO affiliation data for Stratum Med ACO (MSSP, ACO ID A4527) and Avera Prairie View ACO (MSSP, ACO ID A4692).

What billing organization is linked to Thomas J. Wente, DO?

Thomas J. Wente, DO is linked to FAMILY HEALTH CARE OF SIOUXLAND PLC (billing NPI 1437170685) in the available physician profile data.

Does Thomas J. Wente, DO have Open Payments data?

Thomas J. Wente, DO has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.